|
2026
|
G/S
|
Cryopreservation services.
Medical services relating to the removal, treatment and processing of ... |
|
|
G/S
|
Cryopreservation services. Medical services relating to the removal, treatment and
processing of... |
|
|
G/S
|
Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of ... |
|
|
G/S
|
Downloadable chatbot software using artificial intelligence (AI) for the management, coordination... |
|
|
G/S
|
Medicinal preparations for the treatment and prevention of cancer and infectious diseases; pharma... |
|
|
G/S
|
Medicinal preparations for the treatment and prevention of
cancer and infectious diseases; pharm... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of infectious
diseases; medicinal preparations for... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of infectious diseases; medicinal preparations for ... |
|
|
G/S
|
Medicinal preparations for the treatment and prevention of cancer and infectious diseases; Biolog... |
|
|
G/S
|
Medicinal preparations for the treatment and prevention of cancer and infectious diseases; Pharma... |
|
|
Invention
|
Anktiva and lymphocyte rescue compositions and methods. A method for treating lymphopenia and can... |
|
|
Invention
|
Anktiva and lymphocyte rescue compositions and methods.
A method for treating lymphopenia and ca... |
|
|
Invention
|
Methods for preparing and storing immortalized cytolytic natural killer cells.
Provided herein a... |
|
|
Invention
|
Methods of reducing neuroinflammation.
Provided herein are multi-chain chimeric polypeptides and... |
|
|
G/S
|
Cryopreservation services Medical services relating to the removal, treatment and processing of h... |
|
|
Invention
|
Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable gene... |
|
|
Invention
|
Intratumorally injected yeast vaccine.
Disclosed herein are compositions and methods for treatin... |
|
|
Invention
|
Chemokine responsive activated natural killer cells with secondary homing activation for verified... |
|
|
Invention
|
Recombinant eril-15 nk cells.
Systems and methods are presented that provide for improved NK cel... |
|
2025
|
Invention
|
Multi-chain chimeric polypeptides and use thereof in the treatment of liver diseases.
Provided h... |
|
|
G/S
|
Printed publications, namely, brochures, booklets, and teaching materials, in the field of diagno... |
|
|
Invention
|
Interleukin-15, pd-1 antibodies, and taxanes in non-small cell lung cancer. Disclosed herein are ... |
|
|
Invention
|
Interleukin-15, pd-1 antibodies, and taxanes in non-small cell lung cancer.
Disclosed herein are... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of infectious diseases; Medicinal preparations for ... |
|
|
Invention
|
Nk-92 cells with cytokine induced memory-like cytotoxicity and derivatives thereof.
Methods and ... |
|
|
Invention
|
Nk-92 cells with cytokine induced memory-like cytotoxicity and derivatives thereof. Methods and c... |
|
|
G/S
|
Medicinal preparations for the treatment and prevention of lymphopenia, cancer, and infectious di... |
|
|
G/S
|
Medicinal preparations for the treatment and prevention of
lymphopenia, cancer, and infectious d... |
|
|
Invention
|
Methods and systems for cell bed formation during bioprocessing.
Methods and systems are disclos... |
|
|
Invention
|
Single-chain chimeric polypeptides and uses thereof.
Provided herein are single-chain chimeric p... |
|
|
Invention
|
Modified nk-92 hank003 cells for the clinic.
Provided herein are populations of modified NK-92 c... |
|
|
G/S
|
Medicinal preparations for the treatment and prevention of cancer and infectious diseases; biolog... |
|
|
G/S
|
Medicinal preparations for the treatment and prevention of
cancer and infectious diseases; biolo... |
|
|
Invention
|
Elimination of pd-l1-positive malignancies by pd-l1 chimeric antigen receptor-expressing nk cells... |
|
|
Invention
|
Dual-specific binding molecule useful for isolating specific blood cells. Provided herein are met... |
|
|
Invention
|
Dual-specific binding molecule useful for isolating specific blood cells.
Provided herein are me... |
|
|
G/S
|
Cells for scientific, laboratory or medical research; diagnostic preparations other than for medi... |
|
|
G/S
|
Cells for scientific, laboratory or medical research;
diagnostic preparations other than for med... |
|
|
Invention
|
Enzyme based system for production of messenger rna with increased transfection efficiency.
A me... |
|
|
Invention
|
Combined invastion and cytotoxicity assay using chemokine secreting target cells.
Provided herei... |
|
|
Invention
|
Compositions and methods related to potent cytotoxic m-cenk cells from cd3/cd14-depleted apheresi... |
|
|
Invention
|
Genetically modified nk-92 cell line.
This invention is directed to treatment of a subject havin... |
|
|
Invention
|
Neoepitope vaccine delivery vehicle and methods of making the same.
Disclosed herein are mannan ... |
|
|
Invention
|
Anti-slamf7 antibodies and therapeutics. Anti-SLAMF7 Fab fragments, antibodies, biparatopic antib... |
|
|
Invention
|
Anti-slamf7 antibodies and therapeutics.
Anti-SLAMF7 Fab fragments, antibodies, biparatopic anti... |
|
|
Invention
|
Primary nk car constructs and methods.
Disclosed herein are recombinant nucleic acids, comprisin... |
|
|
Invention
|
Fiducial localization with sparse annotations.
A system and method are described. An illustrativ... |
|
|
Invention
|
Methods of treating bronchopulmonary dysplasia.
Provided herein are multi-chain chimeric polypep... |
|
|
Invention
|
Content authentication and validation via multi-factor digital tokens, systems, and methods.
Aut... |
|
|
Invention
|
Elimination of cd19-positive lymphoid malignancies by cd19-car expressing nk cells.
Provided her... |
|
|
Invention
|
Compositions and methods for producing il-16. An NK cell lysate is provided herein that includes ... |
|
|
Invention
|
Interleukin-15 superagonist n-803 in people experiencing long covid. Disclosed herein are methods... |
|
|
Invention
|
Interleukin-15 superagonist n-803 in people experiencing long covid.
Disclosed herein are method... |
|
|
Invention
|
Compositions and methods for nk-92 cells expressing native cd16. A recombinant NK-92 cell has a c... |
|
|
Invention
|
Anti covid-19 therapies targeting nucleocapsid and spike proteins.
Disclosed herein are methods ... |
|
|
Invention
|
Distributed ledger for medicament administration tracking. An autonomous tracking system receives... |
|
|
Invention
|
Adenoviral vector transduced apheresis product.
An immunotherapeutic composition is contemplated... |
|
|
Invention
|
System and method for administering a pharmaceutical composition with an intravenous tubing set. ... |
|
|
Invention
|
Tumoricidal and antimicrobial compositions and methods.
Provided herein are pharmaceutical compo... |
|
|
Invention
|
Combination therapies for multiple myeloma.
Compositions and methods are provided to treat and p... |
|
2024
|
Invention
|
Systems and methods of analyzing assay images of virus strains using artificial intelligence.
Di... |
|
|
Invention
|
Systems and methods of analyzing assay images of virus strains using artificial intelligence. Dis... |
|
|
Invention
|
Virally educated t cells |
|
2023
|
Invention
|
Treatment of mhc-i negative tumors with nk and t cells.
Methods and compositions are provided he... |
|
|
Invention
|
Methods of modulating circadian clock gene expression.
Provided herein are multi-chain chimeric ... |
|
|
Invention
|
Method of treating pancreatic cancer.
Provided herein are methods of treating unresectable advan... |
